Oral Microbiome and Pancreatic Cancer

CompletedOBSERVATIONAL
Enrollment

732

Participants

Timeline

Start Date

December 1, 1992

Primary Completion Date

December 1, 2010

Study Completion Date

December 1, 2010

Conditions
Pancreatic Cancer
Interventions
OTHER

16S rRNA gene sequencing assay

extraction of genomic DNA from oral samples using the Mobio DNA Isolation Kit. 16S rRNA amplicons covering variable regions V3 to V4 will be generated using primers (347F-5'GGAGGCAGCAGTRRGGAAT'-3' and 803R 5'-CTACCRGGGTATCTAATCC-3')66 incorporating adapters and a sample barcode sequence at PI's lab. Amplicons will be sequenced with the Roche 454 FLX Titanium sequencing system at the NYU genome technology center, following the manufacturer's specifications.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03302637 - Oral Microbiome and Pancreatic Cancer | Biotech Hunter | Biotech Hunter